---
document_datetime: 2023-09-21 19:57:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cellcept-epar-all-authorised-presentations_en.pdf
document_name: cellcept-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.211477
conversion_datetime: 2025-12-19 02:54:52.676798
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                              | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                        |
|------------------|-------------------|------------|--------------------------------------------------|---------------------------|-----------------------|---------------------------|----------------------------------|
| EU/1/96/005/001  | CellCept          | 250 mg     | Capsule, hard                                    | Oral use                  | blister (PVC/alu)     |                           | 100 capsules                     |
| EU/1/96/005/002  | CellCept          | 500 mg     | Film-coated tablet                               | Oral use                  | blister (PVC/alu)     |                           | 50 tablets                       |
| EU/1/96/005/003  | CellCept          | 250 mg     | Capsule, hard                                    | Oral use                  | blister (PVC/alu)     |                           | 300 capsules                     |
| EU/1/96/005/004  | CellCept          | 500 mg     | Film-coated tablet                               | Oral use                  | blister (PVC/alu)     |                           | 150 (3 x 50) tablets (multipack) |
| EU/1/96/005/005  | CellCept          | 500 mg     | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass)          |                           | 4 vials                          |
| EU/1/96/005/006  | CellCept          | 1 g/5 ml   | Powder for oral suspension                       | Oral use                  | bottle (HDPE)         | 110g                      | 1 bottle                         |
| EU/1/96/005/007  | CellCept          | 250 mg     | Capsule, hard                                    | Oral use                  | blister (PVC/alu)     |                           | 300 (3x100) capsules (multipack) |